MEF2D and Parkinson disease: According to a study it was observed that injecting antagomiR-421 into SNpc-protected DA neurons in 6-OHDA-treated PD mice, negatively regulates the expression of myocyte enhancer factor 2D (MEF2D) by directly binding to MEF2D mRNA.